Predicting Cancer Risk With Digital and Molecular Markers

NCT06962670 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

1250

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Lung Cancer
Colorectal Cancer
Gynecologic Cancer

Interventions

OTHER: Biomaterial collection
OTHER: BayPass mobile application

Sponsor

University of Erlangen-Nürnberg Medical School